1. Home
  2. WGS vs TSLX Comparison

WGS vs TSLX Comparison

Compare WGS & TSLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGS
  • TSLX
  • Stock Information
  • Founded
  • WGS 2017
  • TSLX 2010
  • Country
  • WGS United States
  • TSLX United States
  • Employees
  • WGS N/A
  • TSLX N/A
  • Industry
  • WGS Retail: Computer Software & Peripheral Equipment
  • TSLX Investment Managers
  • Sector
  • WGS Technology
  • TSLX Finance
  • Exchange
  • WGS Nasdaq
  • TSLX Nasdaq
  • Market Cap
  • WGS 2.4B
  • TSLX 2.2B
  • IPO Year
  • WGS N/A
  • TSLX 2014
  • Fundamental
  • Price
  • WGS $166.40
  • TSLX $21.73
  • Analyst Decision
  • WGS Strong Buy
  • TSLX Buy
  • Analyst Count
  • WGS 8
  • TSLX 10
  • Target Price
  • WGS $130.63
  • TSLX $23.50
  • AVG Volume (30 Days)
  • WGS 536.5K
  • TSLX 493.1K
  • Earning Date
  • WGS 10-28-2025
  • TSLX 11-04-2025
  • Dividend Yield
  • WGS N/A
  • TSLX 9.46%
  • EPS Growth
  • WGS N/A
  • TSLX N/A
  • EPS
  • WGS 0.07
  • TSLX 2.04
  • Revenue
  • WGS $402,190,000.00
  • TSLX $464,512,000.00
  • Revenue This Year
  • WGS $39.54
  • TSLX N/A
  • Revenue Next Year
  • WGS $22.50
  • TSLX N/A
  • P/E Ratio
  • WGS $2,298.07
  • TSLX $10.62
  • Revenue Growth
  • WGS 50.50
  • TSLX N/A
  • 52 Week Low
  • WGS $55.17
  • TSLX $18.58
  • 52 Week High
  • WGS $170.75
  • TSLX $25.17
  • Technical
  • Relative Strength Index (RSI)
  • WGS 74.87
  • TSLX 51.60
  • Support Level
  • WGS $119.43
  • TSLX $20.68
  • Resistance Level
  • WGS $147.71
  • TSLX $21.89
  • Average True Range (ATR)
  • WGS 9.54
  • TSLX 0.44
  • MACD
  • WGS 3.23
  • TSLX 0.09
  • Stochastic Oscillator
  • WGS 92.28
  • TSLX 88.24

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

Share on Social Networks: